Sorafenib treatment alters immunosuppressive phenotypes in hepatocellular carcinoma

( < i > JCI Journals < /i > ) In this issue of JCI Insight, Yasmin Thanavala and colleagues at Roswell Park Cancer Institute evaluated the immune response in a small cohort of patients with advanced hepatocellular carcinoma before and after treatment with sorafenib.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news